In the entire database, seborrheic dermatitis (4.3% ... according to new research from the National Eczema Association. “Many forms of eczema share overlapping symptoms, contributors and ...

It's important to note that itch is the most burdensome symptom of seborrheic dermatitis," says Dr. Woolerry-Lloyd. She also ...

A diagnosis of POD should be considered with young female and pediatric patients who do not respond to treatment for presumed rosacea, seborrheic dermatitis, or acne vulgaris. The precise etiology ...

Kymera Therapeutics announced new clinical trials for KT-621, targeting atopic dermatitis and asthma, with data expected in 2025 and 2026. Kymera Therapeutics has announced the initiation of ...

As an added bonus, the company claims that according to clinical ... overgrowth. Research suggests selenium sulfide is just as effective as ketoconazole in treating seborrheic dermatitis ...

April 22, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical ... severe atopic dermatitis (AD). The Company expects to report data from the BroADen trial in the fourth ...

The representation of Black and Asian adults is on the rise in atopic dermatitis clinical trials, according to a study. As ...

is being developed as a topical treatment for atopic dermatitis (AD), the most common form of eczema. Zabalafin Hydrogel has demonstrated strong efficacy and safety in Phase 2a clinical trials ...

It is often confused with acne vulgaris, rosacea, and seborrheic dermatitis. The condition's precise etiology remains unknown, though it is often triggered by topical corticosteroids. Oral and ...

First topical therapeutic to directly treat the immuno-inflammatory and bacterial causes of the disease at all stages, from AD onset through infection Alphyn Biologics is a clinical-stage ...